OTCMMSTKY
Market cap5.66bUSD
, Last price
0.00USD
Name
MatsukiyoCocokara & Co
Chart & Performance
Profile
MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies in Japan. As of June 30, 2020, it operated through a network of 1,726 stores in 47 prefectures in Japan. MatsukiyoCocokara & Co. was founded in 1932 and is based in Matsudo, Japan.
IPO date
Oct 01, 2007
Employees
13,657
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 1,022,531,000 7.49% | 951,247,000 30.31% | 729,969,000 31.08% | |||||||
Cost of revenue | 924,573,000 | 624,058,000 | 491,360,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 97,958,000 | 327,189,000 | 238,609,000 | |||||||
NOPBT Margin | 9.58% | 34.40% | 32.69% | |||||||
Operating Taxes | 28,630,000 | 24,141,000 | 15,016,000 | |||||||
Tax Rate | 29.23% | 7.38% | 6.29% | |||||||
NOPAT | 69,328,000 | 303,048,000 | 223,593,000 | |||||||
Net income | 52,347,000 29.11% | 40,545,000 17.94% | 34,377,000 59.14% | |||||||
Dividends | (13,252,000) | (10,580,000) | (8,272,000) | |||||||
Dividend yield | 1.30% | 0.36% | 0.46% | |||||||
Proceeds from repurchase of equity | (3,679,000) | (11,698,000) | (11,644,000) | |||||||
BB yield | 0.36% | 0.40% | 0.64% | |||||||
Debt | ||||||||||
Debt current | 20,075,000 | 2,114,000 | 2,640,000 | |||||||
Long-term debt | 1,881,000 | 21,315,000 | 23,916,000 | |||||||
Deferred revenue | 17,857,000 | 16,649,000 | ||||||||
Other long-term liabilities | 20,654,000 | 3,334,000 | 3,472,000 | |||||||
Net debt | (120,104,000) | (167,346,000) | (134,572,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 63,506,000 | 64,061,000 | 39,812,000 | |||||||
CAPEX | (21,965,000) | (16,746,000) | (10,966,000) | |||||||
Cash from investing activities | (22,760,000) | (19,669,000) | (15,485,000) | |||||||
Cash from financing activities | (18,273,000) | (23,734,000) | (20,337,000) | |||||||
FCF | 99,000,000 | 306,667,000 | 130,346,000 | |||||||
Balance | ||||||||||
Cash | 117,720,000 | 95,224,000 | 74,519,000 | |||||||
Long term investments | 24,340,000 | 95,551,000 | 86,609,000 | |||||||
Excess cash | 90,933,450 | 143,212,650 | 124,629,550 | |||||||
Stockholders' equity | 330,423,000 | 766,767,000 | 722,655,000 | |||||||
Invested Capital | 465,558,550 | 367,820,350 | 371,213,450 | |||||||
ROIC | 16.64% | 82.01% | 84.33% | |||||||
ROCE | 17.33% | 62.60% | 47.21% | |||||||
EV | ||||||||||
Common stock shares outstanding | 417,858 | 422,376 | 417,137 | |||||||
Price | 2,439.50 -65.20% | 7,010.00 61.71% | 4,335.00 -12.07% | |||||||
Market cap | 1,019,364,591 -65.57% | 2,960,858,718 63.74% | 1,808,288,587 -12.07% | |||||||
EV | 899,707,591 | 3,265,693,718 | 2,131,552,587 | |||||||
EBITDA | 120,325,000 | 348,029,000 | 253,470,000 | |||||||
EV/EBITDA | 7.48 | 9.38 | 8.41 | |||||||
Interest | 57,000 | 53,000 | 60,000 | |||||||
Interest/NOPBT | 0.06% | 0.02% | 0.03% |